13D/13G Filings - Bain Capital Life Sciences Opportunities IV, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-01-13
4:24 pm
Sale
2025-01-0813GOlema Pharmaceuticals, Inc.
OLMA
Bain Capital Life Sciences Opportunities IV, L.P.7,095,780
9.990%
-374,434decrease
(-5.01%)
Filing
History
2024-12-11
4:30 pm
Purchase
2024-12-0413GOlema Pharmaceuticals, Inc.
OLMA
Bain Capital Life Sciences Opportunities IV, L.P.7,470,214
9.990%
7,470,214increase
(New Position)
Filing
History